Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
about
Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndromeScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens.High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.Endogenous Sex Steroid Hormones, Lipid Subfractions, and Ectopic Adiposity in Asian Indians.Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.The effects of apolipoprotein B depletion on HDL subspecies composition and functionComparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome.High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery DiseaseEvidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.Role of Estrogens in the Regulation of Liver Lipid Metabolism.Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.
P2860
Q26738511-1BC636C4-6E99-4138-BE94-AA649E841479Q28390200-EEFA5667-959B-4CA4-ACF9-32434046920FQ35036648-F9D35856-CE25-4757-AC24-85ED91288643Q35802117-C7A956D2-D1D3-406D-8014-A6513150157DQ36417490-F7CBACEF-160C-48EC-B98E-1EB0A0A76DDEQ36433627-3F27DC34-139B-45DF-AC42-6EC078D09232Q36731786-006D776D-259E-4754-BA90-5ED7EBC24186Q37409121-ED2D7526-27FD-4D97-ACB9-E3142D06622CQ37675416-10AACE04-7A73-4791-842C-D263C3DE4EA5Q38507866-A3C82513-C6EC-47FB-86B1-3A0FF843DEAAQ45204878-AA382E62-C282-4C27-B3C8-43D0A129481DQ47235288-EDA6C3DA-0CF6-4678-9A0F-31B4310CA135Q47311531-DAB46B71-E422-4937-8A8E-39A81FE1233DQ48126292-DE497D4F-2573-4C2F-97E3-8F49F5DAFC6DQ54936700-19503EEA-6F43-4100-BE00-B294393043BC
P2860
Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Decreased cholesterol efflux c ...... file in young women with PCOS.
@ast
Decreased cholesterol efflux c ...... file in young women with PCOS.
@en
Decreased cholesterol efflux c ...... file in young women with PCOS.
@nl
type
label
Decreased cholesterol efflux c ...... file in young women with PCOS.
@ast
Decreased cholesterol efflux c ...... file in young women with PCOS.
@en
Decreased cholesterol efflux c ...... file in young women with PCOS.
@nl
prefLabel
Decreased cholesterol efflux c ...... file in young women with PCOS.
@ast
Decreased cholesterol efflux c ...... file in young women with PCOS.
@en
Decreased cholesterol efflux c ...... file in young women with PCOS.
@nl
P2093
P2860
P356
P1476
Decreased cholesterol efflux c ...... file in young women with PCOS.
@en
P2093
Andrea Roe
Anuja Dokras
Daniel Rader
Jennifer Hillman
Martin Playford
Mathew Smith
Nehal N Mehta
Samantha Butts
P2860
P304
P356
10.1210/JC.2013-3918
P407
P577
2014-02-10T00:00:00Z